Century Therapeutics Stock Forecast - Simple Moving Average

IPSC Stock  USD 1.26  0.02  1.61%   
The Simple Moving Average forecasted value of Century Therapeutics on the next trading day is expected to be 1.25 with a mean absolute deviation of 0.06 and the sum of the absolute errors of 3.58. Century Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Century Therapeutics stock prices and determine the direction of Century Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Century Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
  
At present, Century Therapeutics' Fixed Asset Turnover is projected to slightly decrease based on the last few years of reporting. The current year's Asset Turnover is expected to grow to 0.01, whereas Inventory Turnover is projected to grow to (20.02). . The current year's Common Stock Shares Outstanding is expected to grow to about 62 M, whereas Net Loss is forecasted to decline to (158.1 M).
A two period moving average forecast for Century Therapeutics is based on an daily price series in which the stock price on a given day is replaced by the mean of that price and the preceding price. This model is best suited to price patterns experiencing average volatility.

Century Therapeutics Simple Moving Average Price Forecast For the 23rd of November

Given 90 days horizon, the Simple Moving Average forecasted value of Century Therapeutics on the next trading day is expected to be 1.25 with a mean absolute deviation of 0.06, mean absolute percentage error of 0.01, and the sum of the absolute errors of 3.58.
Please note that although there have been many attempts to predict Century Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Century Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Century Therapeutics Stock Forecast Pattern

Backtest Century TherapeuticsCentury Therapeutics Price PredictionBuy or Sell Advice 

Century Therapeutics Forecasted Value

In the context of forecasting Century Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Century Therapeutics' downside and upside margins for the forecasting period are 0.01 and 5.88, respectively. We have considered Century Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
1.26
1.25
Expected Value
5.88
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Century Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Century Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria109.2724
BiasArithmetic mean of the errors 0.0127
MADMean absolute deviation0.0607
MAPEMean absolute percentage error0.0419
SAESum of the absolute errors3.58
The simple moving average model is conceptually a linear regression of the current value of Century Therapeutics price series against current and previous (unobserved) value of Century Therapeutics. In time series analysis, the simple moving-average model is a very common approach for modeling univariate price series models including forecasting prices into the future

Predictive Modules for Century Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Century Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Century Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.061.255.89
Details
Intrinsic
Valuation
LowRealHigh
0.194.839.47
Details
7 Analysts
Consensus
LowTargetHigh
14.3015.7117.44
Details

Other Forecasting Options for Century Therapeutics

For every potential investor in Century, whether a beginner or expert, Century Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Century Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Century. Basic forecasting techniques help filter out the noise by identifying Century Therapeutics' price trends.

Century Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Century Therapeutics stock to make a market-neutral strategy. Peer analysis of Century Therapeutics could also be used in its relative valuation, which is a method of valuing Century Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Century Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Century Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Century Therapeutics' current price.

Century Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Century Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Century Therapeutics shares will generate the highest return on investment. By undertsting and applying Century Therapeutics stock market strength indicators, traders can identify Century Therapeutics entry and exit signals to maximize returns.

Century Therapeutics Risk Indicators

The analysis of Century Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Century Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting century stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Century Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Century Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Century Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Century Therapeutics Stock:
Check out Historical Fundamental Analysis of Century Therapeutics to cross-verify your projections.
For information on how to trade Century Stock refer to our How to Trade Century Stock guide.
You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Century Therapeutics. If investors know Century will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Century Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.83)
Revenue Per Share
0.037
Quarterly Revenue Growth
4.345
Return On Assets
(0.21)
Return On Equity
(0.63)
The market value of Century Therapeutics is measured differently than its book value, which is the value of Century that is recorded on the company's balance sheet. Investors also form their own opinion of Century Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Century Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Century Therapeutics' market value can be influenced by many factors that don't directly affect Century Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Century Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Century Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Century Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.